Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Non-Current Debt (2021 - 2023)

Pulse Biosciences (PLSE) has 3 years of Non-Current Debt data on record, last reported at $65.0 million in Q1 2023.

  • For Q1 2023, Non-Current Debt changed N/A year-over-year to $65.0 million; the TTM value through Mar 2023 reached $65.0 million, changed N/A, while the annual FY2022 figure was $65.0 million, N/A changed from the prior year.
  • Non-Current Debt reached $65.0 million in Q1 2023 per PLSE's latest filing, roughly flat from $65.0 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $65.0 million in Q3 2022 and bottomed at $41.0 million in Q1 2021.
  • Average Non-Current Debt over 3 years is $59.0 million, with a median of $65.0 million recorded in 2022.